铁基酸盐结合剂对接受维持透析的患者死亡率和心血管事件的影响
Akihito Tanaka1, Sho Sasaki2,3, Hisashi Noma4
1Department of Nephrology, Nagoya University Hospital, Nagoya, Aichi, Japan.
Scientific reports
|September 25, 2023
概括
铁基酸盐结合剂显示,与不使用结合剂相比,在血液透析患者中减少心血管事件和死亡的趋势. 然而,与非铁结合剂的直接比较在统计学上并不显著,因此需要进一步研究.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性病 (CKD) 中的高酸血症管理通常涉及酸盐结合剂.
- 铁基酸盐结合剂越来越多地用于接受维持血液透析的CKD患者.
- 需要现实世界的数据来评估不同类型的酸盐结合剂对心血管的影响.
研究的目的:
- 调查铁基与非铁基酸盐结合剂的使用与血液透析患者的心血管事件之间的关联.
- 为了比较使用不同类型的酸盐结合剂的患者之间的心血管事件发生率和全因死亡率.
- 在现实环境中评估基于铁的酸盐结合剂的安全性和有效性.
主要方法:
- 一个队列研究,利用来自日本维护血液透析的成年患者的真实数据.
- 随时间变化的暴露分类:"以铁为基础"",仅以非铁为基础"和"不使用"的酸盐结合剂.
- 边缘结构考克斯回归模型应用于解决时间依赖的混;主要结果:心血管事件和所有原因死亡的组合.
主要成果:
- 铁基 (HR 0.35 [0.24, 0.52]) 和非铁基 (HR 0.44 [0.33, 0.58]) 酸盐结合剂与与不使用结合剂相比,心血管事件和死亡风险降低有关.
- 铁基结合剂与非铁基结合剂的危险比率为0.81 (0.58,1.13),表明没有统计学上显著的差异.
- 在基线时,15%的患者使用铁基结合剂,61%仅使用非铁基结合剂.
结论:
- 与不使用结合剂相比,铁基和非铁基酸盐结合剂在血液透析患者中显著减少心血管事件和全因死亡率.
- 在比较铁基与非铁基酸盐结合剂时,在心血管事件的风险上没有观察到统计学上显著的差异.
- 需要进一步的研究,以确定铁基酸盐结合剂是否能在这个患者群体中提供优越的心血管保护.
更多相关视频
08:21Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method
Published on: May 18, 2018
14.6K
08:13Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
Published on: March 22, 2016
10.6K
相关概念视频
01:25Peritoneal Dialysis III: Nursing Management
31
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
31
01:28Chronic Kidney Disease III: Interprofessional Care
28
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
28
01:24Chronic Kidney Disease II: Clinical Manifestations
16
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
16
01:25Hemodialysis III: Nursing Management
31
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
31
01:24Hemodialysis II: Procedure and Complications
27
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
27
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
26
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
26